
News|Articles|October 25, 2012
ACIP recommends bacterial meningitis vaccine for at-risk infants
The Advisory Committee for Immunization Practices (ACIP) voted to recommend the use of Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine (MenHibrix, GlaxoSmithKline) in infants at increased risk for bacterial meningitis.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Challenges & Solutions behind post-acute care models with OneHome's Noel Gilliam
2
Fecal Transplants with Immunotherapy Extend Survival in Advanced Melanoma Patients
3
Study explores growth hormone signaling in bladder cancer
4
DCIS Redefined: Circulating Tumor Cells Prove Early Dissemination and Challenge the 'Preinvasive' Label
5


















































